TransMaxF-500 Transfection Reagent
- Detail
- Description
- COA
- User Guide
- Formula
- Parameters
| Catalog Number | Product Size | Unit-price |
| B3500-173 | 0.3ML | ($）178.6 |
| B3500-174 | 0.75ML | ($）285.5 |
| B3500-175 | 1.5ML | ($）500.0 |
| Cell Type |
Established Cell Lines, Hard-to-Transfect Cells, Primary Cells, Stem Cells |
| Sample Type (Specific) | Plasmid DNA, RNAi Plasmids (shRNA, miR), Synthetic siRNA |
| Transfection Technique | Lipid-Based Transfection |
| Serum Compatible | Yes |
| Shelf life | 24months from date of manufacture |
| Shipping Condition | Wet Ice |
| Storage conditions | 2–8°C. Do not freeze |
BIOEXPLORER® TransMaxF-500 Transfection Reagent continues to innovate on the basis of previous generations.Including the most advanced liposome nanoparticle technology, this reagent can enhance cell activity while pursuing higher transfection efficiency. It is widely applicable to difficult and common cell types (such as HEK)293 and Hela cells.
Features
Provides excellent performance to achieve a high transfection efficiency for difficult transfected cell lines
Very low cytotoxicity
Compared with other transfection agents, the transfection efficiency is higher and the dosage is lower
Applicable to a wider range of cells, effectively transfect difficult transfected cell lines
Effectively Transfected Cell Types
Lung cancer cells (A549, nci-h460); Osteosarcoma cells (u-2 OS, saos-2);Colon cancer cells (Caco2, SW480); Pancreatic cancer cells (panc-1);Skin melanoma cells (sk-mel-28);Fibroblasts (3T3, cos-7);Hepatocytes (HepG2, HuH7) erythroleukemia cells (K562);Breast cancer (MCF7, HS578T); Prostate cancer (LNCap);Myoblasts (C2C12, L6 crl-1458)
CAUTION
Not for human or animal therapeutic use. Uses other than the intended use may be a violation of local law.
